Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease
Viz.ai - the world leader in AI-driven intelligent care coordination, today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease .
- Viz.ai - the world leader in AI-driven intelligent care coordination, today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease .
- Viz.ai uses deep learning to identify suspected pulmonary embolism disease in under two minutes.
- Viz.ai is the only software company to offer an AI-powered care coordination solution for stroke, aortic disease, and pulmonary embolism.
- Pulmonary embolism (PE) is a potentially deadly form of venous thromboembolic disease affecting over 600,000 people worldwide.